Inventor · disambiguated record
John Hayslip
Also filed as: HAYSLIP JOHN
1 granted patent·4 pending applications·1 citations·filing 2020–2024
17Inventor score
Files withABBVIE INC5
Top patents by PatentIndex Score
5 records- 0172US11285159B2Dosing regimens for use in treating myelofibrosis and MPN-related disorders with navitoclaxABBVIE INC·Filed 2020·Granted Mar 29, 2022·1 cites·42 claims
- 0254US2023019186A1Dosing regimens for use in treating myelofibrosis and mpn-related disorders with navitoclaxABBVIE INC·Filed 2022·Application pending·0 cites
- 0354US2024350524A1Dosing regimens for use in preventing relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation with venetoclax in combination with azacitidineABBVIE INC·Filed 2024·Application pending·0 cites
- 0447US2022370481A1Venetoclax dosing regimens for use in treating myelodysplastic syndromes in combination with a cyp3a inhibitor and azacitidineABBVIE INC·Filed 2022·Application pending·0 cites
- 0543US2022378811A1Venetoclax dosing regimens for use in treating myelodysplastic syndromes in combination with azacitidineABBVIE INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Hayslip files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →